Livzon Pharma Confirms RMB1.10 Billion Q3 Dividend, Shareholder Return Plan and Adds New Non-Executive Director

Bulletin Express
Nov 12

Livzon Pharmaceutical Group Inc. (Livzon Pharma, HKEX: 01513) has secured shareholder approval for three key ordinary resolutions at its Second Extraordinary General Meeting (EGM) held on 12 November 2026 in Zhuhai, Guangdong.

Dividend Distribution • Shareholders endorsed a third-quarter cash dividend of RMB 12.39 (tax inclusive) per 10 shares, equivalent to RMB 1.239 per share. • The payout totals RMB 1.10 billion. • A-share holders on record after trading hours of 24 November 2026 will receive the dividend in RMB. • H-share holders on record at the close of 26 November 2026 will be paid in Hong Kong dollars at an exchange rate of HK$1 = RMB 0.85633, translating to approximately HK$14.47 per 10 H Shares. • Dividend cheques are scheduled for dispatch on or before 23 December 2026 via the company’s paying agent, Industrial and Commercial Bank of China (Asia) Limited. • Withholding tax will be applied at 20 % for overseas individual investors and 10 % for non-resident enterprise shareholders, in accordance with PRC tax regulations. Domestic investors under Southbound Trading Link will follow prevailing policies.

Board Changes • Ms Zhu Linlin has been appointed as Non-Executive Director, effective immediately and co-terminous with the current 12th Board session. The Board continues to comprise two executive directors, three non-executive directors (including Ms Zhu), one employee representative director and four independent non-executive directors.

Shareholder Participation and Voting • The EGM drew 540 shareholders and proxies representing 433.09 million shares, or 48.78 % of Livzon Pharma’s 887.91 million issued shares. • All three resolutions—director appointment, Q3 profit distribution plan, and the 2026-2028 shareholder return plan—passed with support exceeding 98 % of votes cast. Grant Thornton (Special General Partnership) acted as scrutineer, and Guangdong Chongli Law Firm affirmed the legality of the meeting and its outcomes.

Key Dates for H-Shareholders • Last day to trade cum-dividend: 24 November 2026 • Ex-dividend date: 25 November 2026 • Record date: 26 November 2026

The company will issue a separate notice outlining dividend payment arrangements for A-share investors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10